Pifeltro

Chemical Namedoravirine
Dosage FormTablet (oral; 100 mg)
Drug ClassAntivirals
SystemBlood
CompanyMerck & Co.
Approval Year2018

Indication

  • To treat HIV-1 infection in conjunction with other antiretroviral agents in adults with no previous antiretroviral treatment history.
Last updated on 10/30/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Pifeltro (Doravirine) Prescribing Information2018Merck & Co., Inc., Whitehouse Station, NJ